Symbolbild · KI-generiert
SpyGlass Pharma, Inc.
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| SpyGlass Pharma, Inc. | SGP | NASDAQ | 753 Mio. USD |
| CryoPort, Inc. | CYRX | NASDAQ | 761 Mio. USD |
| Design Therapeutics, Inc. | DSGN | NASDAQ | 761 Mio. USD |
| Anteris Technologies Global Corp. | AVR | NASDAQ | 763 Mio. USD |
| Candel Therapeutics, Inc. | CADL | NASDAQ | 733 Mio. USD |
| CCL Industries Inc. Unlimited Class A Voting Shares | CCL.A | TSX | 774 Mio. USD |
| Aclaris Therapeutics, Inc. | ACRS | NASDAQ | 726 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.